Identification and Characterization of T Cell-Stimulating Antigens from Leishmania by CD4 T Cell Expression Cloning1

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Immunology

• Publication date

  2001-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.166.1.498PMID 11123329
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression Cloning of an Immunodominant Family of Mycobacterium tuberculosis Antigens Using Human Cd4+ T Cells

  2000cited by this paper
• Antigen presentation by macrophages harboring intravesicular pathogens.

  1999cited by this paper
• Leishmaniasis.

  1999cited by this paper
• Antigenicity of the Leishmania infantum histones H2B and H4 during canine viscerocutaneous leishmaniasis

  1999cited by this paper
• Analysis of the humoral immune response against total and recombinant antigens of Leishmania infantum: correlation with disease progression in canine experimental leishmaniasis.

  1999cited by this paper
• Recent trends in vaccine development and immunization.

  1999cited by this paper
• Susceptibility to infectious diseases: Leishmania as a paradigm.

  1999cited by this paper
• Human and Murine Immune Responses to a NovelLeishmania major Recombinant Protein Encoded by Members of a Multicopy Gene Family

  1998cited by this paper
• Molecular cloning of the glycosomal malate dehydrogenase of Trypanosoma brucei.

  1998cited by this paper
• Histone genes in trypanosomatids.

  1998cited by this paper
• A physical map of the Leishmania major Friedlin genome.

  1998cited by this paper
• Leishmania and human immunodeficiency virus coinfection: the first 10 years

  1997cited by this paper
• Molecular characterization of the heat-inducible LmSTI1 protein of Leishmania major.

  1997cited by this paper
• Regulator and effector functions of T‐cell subsets in human Leishmanaia infections

  1997cited by this paper
• A Leishmania protein that modulates interleukin (IL)‐12, IL‐10 and tumor necrosis factor‐α production and expression of B7‐1 in human monocyte‐derived antigen‐presenting cells

  1997cited by this paper
• Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis.

  1996cited by this paper
• Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.

  1996cited by this paper
• Epidemic Visceral Leishmaniasis in Southern Sudan: Treatment of Severely Debilitated Patients under Wartime Conditions and with Limited Resources

  1996cited by this paper
• Clinical spectrum of Leishmaniasis.

  1996cited by this paper
• Differential expression of Leishmania major beta-tubulin genes during the acquisition of promastigote infectivity.

  1996cited by this paper
• Expression cloning of a protective Leishmania antigen.

  1995cited by this paper
• Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response

  1995cited by this paper
• The regulation of immunity to Leishmania major.

  1995cited by this paper
• TH2-type infiltrating T cells in nickel-induced contact dermatitis.

  1995cited by this paper
• Antigen presentation by Leishmania mexicana‐infected macrophages: Activation of helper T cells specific for amastigote cysteine proteinases requires intracellular killing of the parasites

  1995cited by this paper
• Control of the leishmaniases. Report of a WHO Expert Committee.

  1992cited by this paper
• Experimental leishmaniasis in humans: review.

  1991cited by this paper
• Structure and regulation of histone H2B mRNAs from Leishmania enriettii

  1991cited by this paper
• Leishmania major: production of recombinant gp63, its antigenicity and immunogenicity in mice.

  1990cited by this paper
• Experiences with vaccines against cutaneous leishmaniasis: of men and mice

  1989cited by this paper
• Functional heterogeneity of CD4+ T cells in leishmaniasis.

  1989cited by this paper
• Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes.

  1988cited by this paper
• Membrane glycoprotein M-2 protects against Leishmania amazonensis infection

  1988cited by this paper
• An analysis of T cell responsiveness in Indian kala-azar.

  1987cited by this paper
• A prospective study of visceral leishmaniasis in an endemic area of Brazil.

  1986cited by this paper
• New perspectives on a subclinical form of visceral leishmaniasis.

  1986cited by this paper
• Biology of Leishmania and leishmaniasis.

  1985cited by this paper
• Purification of particulate malate dehydrogenase and phosphoenolpyruvate carboxykinase from Leishmania mexicana mexicana.

  1985cited by this paper

• Immunopeptidomics of cutaneous leishmaniasis patients reveals the natural antigenic landscape

  2026cites this paper
• Diagnostic potential of GLP recombinant antigens in whole blood assays for Leishmania infantum infection

  2025cites this paper
• CD4+ and CD8+ T-cell multi-epitope chimeric protein associated with an MPLA adjuvant induce protective efficacy and long-term immunological memory for the immunoprophylaxis of American Tegumentary Leishmaniasis.

  2024cites this paper
• Protective efficacy of multiepitope vaccines constructed from common antigens of Eimeria species in chickens

  2023cites this paper
• A state-of-the-art methodology for high-throughput in silico vaccine discovery against protozoan parasites and exemplified with discovered candidates for Toxoplasma gondii

  2023cites this paper
• Protective Efficacy Induced by the Common Eimeria Antigen Elongation Factor 2 against Challenge with Three Eimeria Species in Chickens

  2023cites this paper
• Identification of T cell antigens in the 21st century, as difficult as ever.

  2022cites this paper
• Transcutaneous immunization using SLA or rLACK skews the immune response towards a Th1 profile but fails to protect BALB/c mice against a Leishmania major challenge.

  2019cites this paper
• Leishmania infantum β-Tubulin Identified by Reverse Engineering Technology through Phage Display Applied as Theranostic Marker for Human Visceral Leishmaniasis

  2019cites this paper
• Diagnostic application of recombinant Leishmania proteins and evaluation of their in vitro immunogenicity after stimulation of immune cells collected from tegumentary leishmaniasis patients and healthy individuals.

  2018cites this paper
• Induction of protective cellular immune responses against experimental visceral leishmaniasis mediated by dendritic cells pulsed with the N‐terminal domain of Leishmania infantum elongation factor‐2 and CpG oligodeoxynucleotides

  2018cites this paper
• Analysis of the Antigenic and Prophylactic Properties of the Leishmania Translation Initiation Factors eIF2 and eIF2B in Natural and Experimental Leishmaniasis

  2018cites this paper
• Immunotherapeutic potential of Leishmania (Leishmania) donovani Th1 stimulatory proteins against experimental visceral leishmaniasis.

  2018cites this paper
• Identification of common immunodominant antigens of Eimeria tenella, Eimeria acervulina and Eimeria maxima by immunoproteomic analysis

  2017cites this paper
• Strategic evaluation of vaccine candidate antigens for the prevention of Visceral Leishmaniasis

  2016cites this paper
• Coadministration of the Three Antigenic Leishmania infantum Poly (A) Binding Proteins as a DNA Vaccine Induces Protection against Leishmania major Infection in BALB/c Mice

  2015cites this paper
• A sand fly salivary protein vaccine shows efficacy against vector-transmitted cutaneous leishmaniasis in nonhuman primates

  2015cites this paper
• Expression and Characterization of Genes by Expressed Sequence Tag Analysis in the Rat Thymus during Regeneration following Acute Thymic Involution Induced by Cyclophosphamide

  2014cites this paper
• Proteomics and African Trypanosomes: Shedding New Light on Host–Vector–Parasite Interactions and Impact on Control Methods

  2014cites this paper
• Genome- and proteome-wide screening strategies for antigen discovery and immunogen design.

  2014cites this paper
• La transfección del gen de ATPasa (tipo vacuolar) de Leishmania mexicana incrementa la virulencia en aislado no virulento de Leishmania enriettii

  2014cites this paper
• Cross-protective effect of a combined L5 plus L3 Leishmania major ribosomal protein based vaccine combined with a Th1 adjuvant in murine cutaneous and visceral leishmaniasis

  2014cites this paper
• Pathogenesis of haematogenous spread in Acanthamoeba castellanii infections

  2013cites this paper
• Case study for a vaccine against leishmaniasis.

  2013cites this paper
• Cathepsin B Gene Disruption Induced Leishmania donovani Proteome Remodeling Implies Cathepsin B Role in Secretome Regulation

  2013cites this paper
• Vaccination with Leishmania histone H1-pulsed dendritic cells confers protection in murine visceral leishmaniasis.

  2012cites this paper
• Vaccination with L. infantum chagasi Nucleosomal Histones Confers Protection against New World Cutaneous Leishmaniasis Caused by Leishmania braziliensis

  2012cites this paper
• A novel recombinant Leishmania donovani p45, a partial coding region of methionine aminopeptidase, generates protective immunity by inducing a Th1 stimulatory response against experimental visceral leishmaniasis.

  2012cites this paper
• A broadly applicable approach to T cell epitope identification: application to improving tumor associated epitopes and identifying epitopes in complex pathogens.

  2011cites this paper
• Effect of A2 gene on infectivity of the nonpathogenic parasite Leishmania tarentolae

  2011cites this paper
• Microtubules as antifungal and antiparasitic drug targets

  2011cites this paper
• Visceral leishmaniasis: immunology and prospects for a vaccine.

  2011cites this paper
• Vaccines for Leishmaniasis: From proteome to vaccine candidates

  2011cites this paper
• Schistosoma japonicum: screening of cercariae cDNA library by specific single-chain antibody against SIEA26-28 ku and immunization experiment of the recombinant plasmids containing the selected genes

  2010cites this paper
• Microarray based gene expression: a novel approach for identification and development of potential drug and effective vaccine against visceral Leishmaniasis

  2010cites this paper
• Tsetse flies, trypanosomes, humans and animals: what is proteomics revealing about their crosstalks?

  2010cites this paper
• Cellular and humoral responses induced by Leishmania histone H2B and its divergent and conserved parts in cutaneous and visceral leishmaniasis patients, respectively.

  2010cites this paper
• Challenges and perspectives in vaccination against leishmaniasis.

  2009cites this paper
• Immunization with inflammatory proteome of Brugia malayi adult worm induces a Th1/Th2-immune response and confers protection against the filarial infection.

  2009cites this paper
• Vaccine development against Trypanosoma cruzi and Leishmania species in the post-genomic era.

  2009cites this paper
• Identification of Mycobacterium tuberculosis vaccine candidates using human CD4+ T-cells expression cloning.

  2009cites this paper
• Vaccination of dogs with six different candidate leishmaniasis vaccines composed of a chimerical recombinant protein containing ribosomal and histone protein epitopes in combination with different adjuvants.

  2009cites this paper
• Mining the Leishmania genome for novel antigens and vaccine candidates

  2009cites this paper
• Identification of total and differentially expressed excreted-secreted proteins from Trypanosoma congolense strains exhibiting different virulence and pathogenicity.

  2009influential citation
• LAS HISTONAS DE LEISHMANIA LEISHMANIA HISTONES

  2009cites this paper
• Identification of Novel Leishmania donovani Antigens that Help Define Correlates of Vaccine-Mediated Protection in Visceral Leishmaniasis

  2009cites this paper
• Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis.

  2009cites this paper
• Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis.

  2008cites this paper
• Transitory or long-lasting immunity to Leishmania major infection: the result of immunogenicity and multicomponent properties of histone DNA vaccines.

  2008cites this paper
• Administration of recombinant parasite beta-tubulin to goldfish (Carassius auratus L.) confers partial protection against challenge infection with Trypanosoma danilewskyi Laveran and Mesnil, 1904.

  2008cites this paper
• Geração e análise da imunogenicidade de plasmídeos contendo epítopos CD8 sub-dominantes expressos em Trypanosoma cruzi

  2008cites this paper
• Discovery of novel vaccine candidates and drug targets against visceral leishmaniasis using proteomics and transcriptomics.

  2008cites this paper
• h 1-stimulatory polyproteins of soluble Leishmania donovani promastigotes anging from 89 . 9 to 97 . 1 kDa offers long-lasting protection against xperimental visceral leishmaniasis

  2008cites this paper
• Proteomic approach for identification and characterization of novel immunostimulatory proteins from soluble antigens of Leishmania donovani promastigotes

  2007cites this paper
• Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant.

  2007cites this paper
• Trypanosoma cruzi ribosomal protein S4: characterization of its coding locus, analysis of transcripts, and antigenicity of the protein.

  2007cites this paper
• Leishmania and the leishmaniases: a parasite genetic update and advances in taxonomy, epidemiology and pathogenicity in humans.

  2007cites this paper
• Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis.

  2006cites this paper
• T-Cell Expression Cloning of Porphyromonas gingivalis Genes Coding for T Helper-Biased Immune Responses during Infection

  2006cites this paper
• Protective and Destructive Immunity in the Periodontium: Part 2—T-cell-mediated Immunity in the Periodontium

  2006cites this paper
• Antibodies that recognize alpha- and beta-tubulin inhibit in vitro growth of the fish parasite Trypanosoma danilewskyi, Laveran and Mesnil, 1904.

  2006cites this paper
• Approaches for the identification of potential excreted/secreted proteins of Leishmania major parasites

  2006cites this paper
• Vaccination with the divergent portion of the protein histone H2B of Leishmania protects susceptible BALB/c mice against a virulent challenge with Leishmania major.

  2006cites this paper
• Identification of Leishmania donovani antigens stimulating cellular immune responses in exposed immune individuals

  2006cites this paper
• ESTUDO DO USO DA RADIAÇÃO IONIZANTE COMO FERRAMENTA DE SELEÇÃO DE FORMAS PROMASTIGOTAS METACÍCLICAS DE Leishmania amazonensis , E A INDUÇÃO DE RESPOSTA IMUNOLÓGICA EM MODELOS EXPERIMENTAIS.

  2006cites this paper
• Antibodies that recognize α- and β-tubulin inhibit in vitro growth of the fish parasite Trypanosoma danilewskyi, Laveran and Mesnil, 1904

  2006cites this paper
• American tegumentary leishmaniasis: antigen-gene polymorphism, taxonomy and clinical pleomorphism.

  2005cites this paper
• Proteomic Approach for Characterization of Immunodominant Membrane-Associated 30- to 36-Kilodalton Fraction Antigens of Leishmania infantum Promastigotes, Reacting with Sera from Mediterranean Visceral Leishmaniasis Patients

  2005cites this paper
• Leishmania donovani: identification of novel vaccine candidates using human reactive sera and cell lines.

  2005cites this paper
• What about Th1/Th2 in cutaneous leishmaniasis vaccine discovery?

  2005cites this paper
• Echinococcus granulosus‐specific T‐cell lines derived from patients at various clinical stages of cystic echinococcosis

  2004cites this paper
• Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.

  2004cites this paper
• Comparative effect of ion calcium and magnesium in the activation and infection of the murine macrophage by Leishmania major.

  2004cites this paper
• Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicity.

  2003cites this paper
• A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum.

  2003cites this paper
• Expression cloning for the discovery of viral antigens and epitopes recognized by T cells.

  2003cites this paper
• Vaccinology for control of apicomplexan parasites: a simplified language of immune programming and its use in vaccine design.

  2002cites this paper
• Rhea Models of the Human Disease Antigens in Murine and Nonhuman Primate Leishmaniasis Induced by Recombinant Protection against Cutaneous

  2001cites this paper
• Tachyzoite-specific isoform of Toxoplasma gondii lactate dehydrogenase is the target antigen of a murine CD4(+) T-cell clone.

  2001cites this paper
• Protection against Cutaneous Leishmaniasis Induced by Recombinant Antigens in Murine and Nonhuman Primate Models of the Human Disease

  2001cites this paper